Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection may trigger alopecia areata in some patients.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 may trigger hair loss conditions like alopecia areata.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

The treatment might help COVID-19 related hair loss, but more research is needed.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Some early COVID-19 mutations in patients predicted future common virus mutations.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Hepatitis B vaccination can trigger HSP, and vitamin D correction and tonsillectomy can effectively manage it.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.